RNA and DNA Microarrays

Methods in Molecular Biology

Volumn 671, Issue , 2011, Pages 3-34

  Sealfon, Stuart C ^a   Chu, Tearina T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

BAC; cDNA; Comparative genomic hybridization; Copy number variation; DNA; Expression; Microarray; RNA; Transcripts

Indexed keywords

COMPLEMENTARY DNA; DNA; RNA;

ANIMAL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; COMPARATIVE GENOMIC HYBRIDIZATION; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METHODOLOGY;

ANIMALS; CHROMOSOMES, ARTIFICIAL, BACTERIAL; COMPARATIVE GENOMIC HYBRIDIZATION; DNA; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA;

MLCS; MLOWN;

EID: 79952196986     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-59745-551-0_1     Document Type: Chapter

References (81)

1. Fleischmann, R.D., et al., (1995) Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science, 269(5223): p. 496–512.
2. International Human Genome Sequencing Consortium, (2004). Finishing the euchro-matic sequence of the human genome. Nature, 431(7011): p. 931–945.
3. Schena, M., (1996).Genome analysis with gene expression microarrays. Bioessays, 18(5): p. 427–431.
4. Vissers, L.E.L.M., et al., (2005). Identification of disease genes by whole genome CGH arrays. Hum. Mol. Genet, 14(suppl_2): p. R215–223.
5. Fu, S., et al., (2008). Peripheral arterial occlu-sive disease: global gene expression analyses sug-gest a major role for immune and inflammatory responses. BMC Genomics, 9(1): p. 369.
6. Lenk, G.M., et al., (2007). Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics, 8: p. 237–249.
7. Seo, D., et al., (2004). Gene expression pheno-types of atherosclerosis. Arterioscler Thromb Vasc Biol, 24: p. 1922–1927.
8. Singhal, S., et al., (2003). Gene expression profiling of malignant mesothelioma. Clin Cancer Res, 9: p. 3080–3097.
9. Schena, M., et al., (1996). Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA, 93(20): p. 10614–10619.
10. DeRisi, J., et al., (1996). Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet, 14(4): p. 457–460.
11. Milano, A., et al., (2008).Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One, 3(7): p. e2696.
12. Schena, M., et al., (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270(5235): p. 467–470.
13. Lander, E.S., et al., (2001). Initial sequencing and analysis of the human genome. Nature, 409(6822): p. 860–921.
14. Bentley, D.R., et al., (2008). Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456(7218): p. 53–59.
15. Cerdeno-Tarraga, A.M., et al., (2003). The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129. Nucleic Acids Res, 31(22): p. 6516–6523.
16. Rew, D.A., (2004). The sequencing of the rat genome. Eur J Surg Oncol, 30(8): p. 905–906.
17. Tettelin, H., et al., (2001). Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science, 293(5529): p. 498–506.
18. Nierman, W.C., et al., (2001). Complete genome sequence of Caulobacter crescentus. Proc Natl Acad Sci USA, 98(7): p. 4136–4141.
19. Check, E., (2002). Draft mouse genome makes public debut. Nature, 417(6885): p. 106.
20. Galitski, T., et al., (1999). Ploidy regulation of gene expression. Science, 285(5425): p. 251–254.
21. Tu, B.P., et al., (2005). Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. Science, 310(5751): p. 1152–1158.
22. Iyer, V.R., et al., (1999). The transcriptional program in the response of human fibroblasts to serum. Science, 283(5398): p. 83–87.
23. Plescia, C., C. Rogler, and L. Rogler, (2001). Genomic expression analysis implicates Wnt signaling pathway and extracellular matrix alterations in hepatic specification and differentiation of murine hepatic stem cells. Differentiation, 68(4–5): p. 254–269.
24. Lee, K.-H., D.-H. Yu, and Y.-S. Lee, (2009). Gene expression profiling of rat cerebral cortex development using cDNA microarrays. Neurochemical Res, 34(6): p. 1030–1038.
25. Nikolova-Krstevski, V., et al., (2008). Gene expression analysis of embryonic stem cells expressing VE-cadherin (CD144) during endothelial differentiation. BMC Genomics, 9(1): p. 240.
26. Zhu, H., H. Yang, M. R. Owen, (2007). Combined microarray analysis uncovers self-renewal related signaling in mouse embryonic stem cells. Syst Synth Biol, 4(1): p. 171–181.
27. Chen, V.C., et al., (2008). Notch signaling respecifies the hemangioblast to a cardiac fate. Nat Biotech, 26(10): p. 1169–1178.
28. Kakar, S.S., et al., (2003). Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis. Gene, 308: p. 67–77.
29. Malyala, A., et al., (2004). Suppression subtractive hybridization and microarray identification of estrogen-regulated hypothalamic genes. Neurochem Res, 29(6): p. 1189–1200.
30. Auger, C.J., H.M. Jessen, and A.P. Auger, (2006). Microarray profiling of gene expression patterns in adult male rat brain following acute progesterone treatment. Brain Res, 1067(1): p. 58–66.
31. Elin Lehrmann, W.J.F., (2008). Transcriptional correlates of human substance use. Ann N Y Acad Sci, 1139(Drug Addiction: Research Frontiers and Treatment Advances): p. 34–42.
32. Runne, H., et al., (2008). Dysregulation of gene expression in primary neuron models of Huntington’s disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry. J Neurosci, 28(39): p. 9723–9731.
33. Salas, R., et al., (2008). Nicotine relieves anxiogenic-like behavior in acetylcholinesterase-R overexpressing mice but not in wild-type mice. Mol Pharmacol, 74(6): p. 1641–1648, mol.108.048454.
34. Bergström, A., et al., (2007). Molecular pathways associated with stress resilience and drug resistance in the chronic mild stress rat model of depression – a gene expression study. J Mol Neurosci, 33: p. 201–215.
35. Venter, J.C., et al., (2001). The sequence of the human genome. Science, 291(5507): p. 1304–1351.
36. Golub, T.R., et al., (1999). Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286(5439): p. 531–537.
37. Perou, C.M., et al., (2000). Molecular portraits of human breast tumours. Nature, 406(6797): p. 747–752.
38. Garber, M.E., et al., (2001). Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA, 98(24): p. 13784–13789.
39. Alizadeh, A.A., et al., (2001). Towards a novel classification of human malignancies based on gene expression patterns. J Pathol, 195(1): p. 41–52.
40. Sørlie, T., et al., (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98(19): p. 10869–10874.
41. Murphy, D.J. and J.R. Brown, (2007). Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infectious Disease, 7: p. 84.
42. Helbig, K.J., et al., (2008). Differential expression of the CXCR3 ligands in chronic hepatitis C, and their modulation by HCV in vitro. J Virol, 83(2): p. 836–846, JVI.01388-08.
43. Mikhailovich, V., et al., (2008). DNA microarrays in the clinic: infectious diseases. Bioessays, 30(7): p. 673–682.
44. Wright, H.J., et al., (2008). Periodontitis associates with a type 1 IFN signature in peripheral blood neutrophils. J Immunol, 181(8): p. 5775–5784.
45. Kaminski, N., et al., (2000). Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis. Proc Natl Acad Sci USA, 97(4): p. 1778–1783.
46. Kinter, J., T. Zeis, and N. Schaeren-Wiemers, (2008). RNA profiling of MS brain tissues. Int MS J, 15(2): p. 51–58.
47. Satoh, J-i., et al., (2008). Neuromyelitis optica/ Devic’s disease: gene expression profiling of brain lesions. Neuropathology, 28(6): p. 561–576.
48. Grünblatt, E., et al., (2007). Comparison analysis of gene expression patterns between sporadic Alzheimer’s and Parkinson’s disease. J Alzheimers Dis, 12(4): p. 291–311.
49. Mash, D.C., et al., (2007). Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS One, 2(11): p. e1187.
50. Colantuoni, C., et al., (2008). Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct Funct, 213(1): p. 255–271.
51. Iwamoto, K., M. Bundo, and T. Kato, (2005). Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet, 14(2): p. 241–253.
52. Chin, K.-V. and A.N.T. Kong, (2002). Application of DNA microarrays in pharma-cogenomics and toxicogenomics. Pharmaceutical Res, 19(12): p. 1773–1778.
53. Duncan, C.E., A.F. Chetcuti, and P.R. Schofield, (2008). Coregulation of genes in the mouse brain following treatment with clozapine, haloperidol, or olanzapine implicates altered potassium channel subunit expression in the mechanism of antipsychotic drug action. Psychiatr Genet, 18(5): p. 226–239.
54. Debouck, C. and P.N. Goodfellow, (1999). DNA microarrays in drug discovery and development. Nat Genet, 21(1 Suppl): p. 48–50.
55. Gerhold, D.L., R.V. Jensen, and S.R. Gullans, (2002). Better therapeutics through microarrays. Nat Genet, 32(Suppl): p. 547–551.
56. Kresse, S., et al., (2008). DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. Mol Cancer, 7(1): p. 48.
57. Ankita, P., et al., (2008). Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia. Am J Hematol, 83(7): p. 540–546.
58. Shaffer, LG., et al., (1993). Familial interstitial deletion 11(p11.12p12) associated with parietal foramina, brachymicrocephaly, and mental retardation. Am J Med Genet, 45(5): p. 581–583.
59. Kallioniemi, A., et al., (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 258(5083): p. 818–821.
60. Mizuguchi, T., et al., (2008). Microarray comparative genomic hybridization analysis of 59 patients with schizophrenia. J Hum Genet, 53(10): p. 914–919.
61. Jiang, M., et al., (2008). Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray. Prostate, 68(14): p. 1496–1509.
62. Staaf, J., et al., (2008). Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH). Hum Mutat, 29(4): p. 555–564.
63. National Institutes of Health, (2001). Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1–3, 2000. Cancer Control, 8(1): p. 55.
64. Goldhirsch, A., et al., (2003). Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol, 21(17): p. 3357–3365.
65. van ’t Veer, L.J., et al., (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415(6871): p. 530–536.
66. van de Vijver, M.J., et al., (2002). A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med, 347(25): p. 1999–2009.
67. Wang, Y., et al., (2005). Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet, 365(9460): p. 671–679.
68. Foekens, J.A., et al., (2006). Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer. J Clin Oncol, 24(11): p. 1665–1671.
69. Chang, J.C., et al., (2003). Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet, 362(9381): p. 362–369.
70. Ma, X.-J., et al., (2004). A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell, 5(6): p. 607–616.
71. Ayers, M., et al., (2004). Gene expression profiles predict complete pathologic response to neo-adjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. J Clin Oncol, 22(12): p. 2284–2293.
72. Gonzalez-Neira, A., et al., (2007). Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies. BMC Genomics, 8(1): p. 299–.
73. Climent, J., et al., (2007). Characterization of breast cancer by array comparative genomic hybridization (1).(MINIREVIEW/ MINISYNTHESE)(Clinical report). Biochem Cell Biol, 85(4): p. 497–508.
74. Telenius, H., et al., (1992). Degenerate oligo-nucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics, 13(3): p. 718–725.
75. Zhang, L., et al., (1992). Whole genome amplification from a single cell: implications for genetic analysis. Proc Natl Acad Sci USA, 89(13): p. 5847–5851.
76. Hosono, S., et al., (2003). Unbiased whole-genome amplification directly from clinical samples. Genome Res, 13(5): p. 954–964.
77. Paez, J.G., et al., (2004). Genome coverage and sequence fidelity of phi29 polymerase-based multiple strand displacement whole genome amplification. Nucleic Acids Res, 32(9): p. e71.
78. Brown, P.O., (2007). Ozone News [cited 1; Available from: http://cmgm.stanford.edu/pbrown/protocols/OzoneNewsVol1.pdf.
79. Brown, P.O. Ozone News 2. 2007 [cited; Available from: http://cmgm.stanford. edu/pbrown/protocols/OzoneNewsVol2. pdf.
80. Fare, T.L., et al., (2003). Effects of atmospheric ozone on microarray data quality. Anal Chem, 75(17): p. 4672–4675.
81. Klass, D. and D. Hogan, (2007). The Ozone Annihilator [cited; Available from: http://cmgm.stanford.edu/pbrown/protocols/Ozone_Prevention.pdf.